EXOSC2 and acute myeloid leukemia: In a preliminary qRT-PCR analysis of four top-ranked RRGs using our limited sample set, we observed trends of elevated mRNA expression for EXOSC2 and LYAR, alongside decreased levels of NSUN5 and RPUSD2 in AML patients compared to controls (Figures 14A–D).